Status:

COMPLETED

Faecal Microbiota Transplantation in Irritable Bowel Syndrome

Lead Sponsor:

Thomayer University Hospital

Collaborating Sponsors:

Charles University, Czech Republic

Conditions:

Irritable Bowel Syndrome With Diarrhea

Irritable Bowel Syndrome Mixed

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Irritable bowel syndrome (IBS) is the most common functional bowel disorder, being present in approximately 10% of adult Europoid population. The etiology of IBS is elusive. Literature indicates that ...

Detailed Description

Three-groups, double-blind, placebo-controlled, randomised, cross-over study in adult patients diagnosed with IBS (diarrhoeal or mixed form) according to Rome IV criteria. Each study subject will unde...

Eligibility Criteria

Inclusion

  • Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) or Irritable Bowel Syndrome with mixed bowel habits (IBS-M) according to the Rome IV criteria

Exclusion

  • The use of antibiotics within one month prior to faecal microbiota transplantation
  • The use of probiotics within one month prior to faecal microbiota transplantation
  • History of inflammatory bowel disease or gastrointestinal malignancy, systemic autoimmune diseases (ongoing or in history)
  • Previous abdominal surgery (other than appendectomy or cholecystectomy or hernioplasty or cesarean section)
  • HIV infection or other active infection
  • Renal or hepatic disease (both defined by biochemistry workup)
  • Diabetes mellitus, abnormal thyroid functions not controlled by thyroid medications
  • Bipolar disorder or schizophrenia (ongoing or history thereof), moderately severe depression defined by Patient Health Questionnaire-9 (PHQ-9) score \> 15
  • Anxiety defined by a Generalised Anxiety Disorder 7 (GAD7) score \> 10
  • Current pregnancy and lactation

Key Trial Info

Start Date :

June 17 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 29 2024

Estimated Enrollment :

61 Patients enrolled

Trial Details

Trial ID

NCT04899869

Start Date

June 17 2021

End Date

April 29 2024

Last Update

May 24 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Thomayer University Hospital

Prague, Czechia, 14059

Faecal Microbiota Transplantation in Irritable Bowel Syndrome | DecenTrialz